Sunil Iyer

Columbia University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (5)

Anand Ashwin Patel

UNITED STATES

View details

Evan Chen

Dana-Farber Cancer Institute

UNITED STATES

View details

Michele Stanchina

University of Miami Health System

UNITED STATES

View details

Jose Augusto Monteiro de Oliveira Novaes

Assistant Professor

Winship Cancer Institute of Emory University

UNITED STATES

View details

Sangeetha Venugopal

Assistant professor

Sylvester Comprehensive Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sunil Iyer

Research Interests

Explore related searches

Contact this professor

Articles (10)

Response and Outcomes of Patients with IDH1/2 Mutated Accelerated/Blast-Phase Myeloproliferative Neoplasms

Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy

Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia

Acute Coagulopathy As an Underappreciated Toxicity of Azacitidine/Venetoclax Induction in AML

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.

Abstract B121: HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplant cyclophosphamide improves clinical outcomes for racial and ethnic minority patients with hematologic malignancies

Long‐term outcomes of patients with conjunctival extranodal marginal zone lymphoma

Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave

Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date.

Collaborators (5)

Anand Ashwin Patel

Evan Chen

Michele Stanchina

Jose Augusto Monteiro de Oliveira Novaes

Sangeetha Venugopal

Make your next move.